Submitted by dcc on Mon, 2023-05-08 16:15 Study Title: A Phase 1 Study of Peposertib (M3814) and Low-Dose Liposomal Doxorubicin (Doxil®) in Patients with Metastatic Leiomyosarcoma and Other Soft Tissue SarcomasCIRB: Adult CIRB - Early Phase EmphasisLead Group: ETCTNStatus: ActiveReview Status: Available to Open
